Xue Tang

PROM1 and CTGF Expression in Childhood MLL-Rearrangement Acute Lymphoblastic Leukemia

F. Wen, Siyi Liu, Sixi Liu, 2022, Journal of oncology.

Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia

Y. Wang, F. Wen, Yi Liu, 2022, Journal of Cancer Research and Clinical Oncology.

High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL

Min Zhang, Xiaowen Chen, F. Wen, 2021, Frontiers in Oncology.

Blinatumomab therapy for B cell acute lymphoblastic leukemia accompanied by persistent or relapsed low-level MRD prior to hematopoietic stem cell transplantation in Chinese children: a case series

F. Wen, Siyi Liu, Ying Wang, 2023, Bulletin of the National Research Centre.

Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia

Y. Wang, F. Wen, Yi Liu, 2022, Journal of Cancer Research and Clinical Oncology.

[E-cadherin Expression in Children with Acute Leukemia and Its Clinical Significance].

B. Bao, Jie Yu, Shaoyan Liang, 2019, Zhongguo shi yan xue ye xue za zhi.

Case report: Clinical features of pediatric acute myeloid leukemia presenting with cardiac tamponade: a case series study and literature review

Sixi Liu, Guichi Zhou, Xue Tang, 2024, Frontiers in oncology.